Angela Lamarca, MD, PhD, MSc

Systematic review and pooled analysis of locoregional therapies in patients with intrahepatic cholangiocarcinoma

Background Locoregional treatments (LRT) including radioembolisation (SIRT), transarterial chemo-embolisation (TACE), hepatic arterial infusion (HAI) of chemotherapy, ex...

Julien Edeline ;

Timothy Jacobs ;

Richard A. Hubner ;

Dan Palmer ;

Philip Johnson ;

Boris Guiu ;

Juan W. Valle ;

Angela Lamarca , MD, PhD, MSc;

06/28/2021

New Agents in Bile Duct Cancer

Angela Lamarca , MD, PhD, MSc;

06/30/2021

How to transform your idea into a research proposal?

Angela Lamarca , MD, PhD, MSc;

07/01/2021

PROOF 301: A multicenter, open-label, randomized, phase 3 trial of infigratinib vs gemcitabine + cisplatin in patients with advanced cholangiocarcinoma with an FGFR2 gene fusion/rearrangement

Background First-line treatment options are limited for patients with advanced cholangiocarcinoma (CCA). Genetic alterations in the fibroblast growth factor receptor (FG...

Teresa Macarulla , MD, PhD;

Sudipta Roychowdhury , MD;

R. Shroff ;

J. Soto ;

G. Pedrioli ;

L. Fumagalli ;

C. dambkowski ;

M. Javle ;

Ghassan Abou-Alfa , MD, MBA;

D. Oh ;

I. Borbath ;

Lovely Goyal ;